A long graft survival of the steatotic liver after the inhibition of chemokine production and the remodeling of the altered extracellular matrix

抑制趋化因子产生和改变的细胞外基质重塑后脂肪变性肝脏的长期移植存活

基本信息

项目摘要

The aim of this research project is to approach an effective strategy against the hepatic ischemia-reperfusion (IR) injury. The IR injury plays a crucial role in the primary non-function after hepatic transplantation using a steatotic graft.Our group has previously found that in the alcoholic fatty liver a neutrophil-chemokine contributes to hepatocyte necrosis which is associated with apoptosis after IR (Hepatology 32:278, 2000). Additionally, in this model in vivo, the suppression of hepatic macrophage activity completely inhibits the production of the chemokine and protects the liver from the extensive necrosis after IR.When we evaluated the above results, we fortunately found that a firm attachment of the chemokine with extracellular matrices was prerequisite for the neutrophil infiltration and inflammatory necrosis in the liver. In an in vivo study using primary hepatocytes, we had an evidence for a contribution of the altered mitochondrial function to hepatic apoptosis in fatty liver.Thus, we raise three possible strategies for graft survival of the fatty livers as follows; 1. An inhibition of the chemokine production; 2. A remodeling of the extracellular matrix in the damaged liver; 3. An improvement of the mitochondrial function of the liver cells.
本研究旨在探讨肝缺血再灌注损伤的有效防治策略。IR损伤在使用脂肪变性移植物的肝移植后的原发性无功能中起关键作用。我们的小组先前发现,在酒精性脂肪肝中,嗜中性粒细胞趋化因子导致肝细胞坏死,这与IR后的细胞凋亡有关(Hepatology 32:278,2000)。此外,在该模型中,在体内,抑制肝巨噬细胞活性完全抑制了生产的趋化因子,并保护肝脏广泛坏死后IR。当我们评估上述结果,我们幸运地发现,一个坚定的附着的趋化因子与细胞外基质是必要的中性粒细胞浸润和炎性坏死的肝脏。在原代肝细胞的体内研究中,我们发现脂肪肝中线粒体功能的改变对肝细胞凋亡有贡献,因此我们提出了三种可能的脂肪肝移植存活策略:1.抑制趋化因子的产生; 2.受损肝脏中细胞外基质的重塑; 3.改善肝细胞的线粒体功能。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamada S.: "Alcoholic fatty liver differentially induces a neutrophil-chemokine and hepatic necrosis after ischemia-reperfusion in rat."Hepatology. 32. 278-288 (2000)
Yamada S.:“酒精性脂肪肝在大鼠缺血再灌注后差异性地诱导中性粒细胞趋化因子和肝坏死。”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Okabe K.: "CD45RC^-γσ^+ T-cell infiltration is associated with immunologic unresponsiveness induced by prior donor-specific blood transfusion in rat hepatic allografts"Hepatology. 33. 877-886 (2001)
Okabe K.:“CD45RC^-γσ^+ T 细胞浸润与大鼠同种异体肝移植物中先前供体特异性输血引起的免疫无反应有关”Hepatology 33. 877-886 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Zhang.JL: "A serine protease inhibitor, N-d-tosyl-L-lysine chloromethyl ketone. prolongs rat hepatic allograft survival"J Surg Res. 96. 296-303 (2001)
张建良:“一种丝氨酸蛋白酶抑制剂,N-d-甲苯磺酰基-L-赖氨酸氯甲基酮。可延长大鼠同种异体肝移植物的存活”J Surg Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Okabe K: "CD45RC-γδ + T-cell infiltration is associated with immunologic unresponsiveness induced by prior donor-specific blood transfusion in rat hepatic allografts"Hepatology. 33(4). 877-886 (2001)
Okabe K:“CD45RC-γδ + T 细胞浸润与大鼠同种异体肝移植物中先前供者特异性输血引起的免疫无反应有关”Hepatology 33(4) (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamada S: "Alcoholic fatty liver differentially induces a neutrophil-chemokine and hepatic necrosis after ischemia-reperfusion in rat"Hepatology. 32. 278-288 (2000)
Yamada S:“酒精性脂肪肝在大鼠缺血再灌注后差异性地诱导中性粒细胞趋化因子和肝坏死”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMADA Shinwa其他文献

YAMADA Shinwa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMADA Shinwa', 18)}}的其他基金

Potentiation of Liver Function Recovery and Its Regeneration by the Modulation of Extracellular Matrix During the Early Phase after Liver Transplantation
肝移植术后早期细胞外基质调节促进肝功能恢复及其再生
  • 批准号:
    10670523
  • 财政年份:
    1998
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Escape from Inhibition of Liver Regeneration in Fibrotic Liver through The Modulation of Extracellular Matrix.
通过细胞外基质的调节摆脱纤维化肝脏中肝脏再生的抑制。
  • 批准号:
    07670637
  • 财政年份:
    1995
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibition of Rejection Reaction by Modulating Actions of Adhesion Molecules on Sinusoidal Endothelial Cells in Rat Liver Allograft.
通过调节粘附分子对大鼠同种异体肝窦内皮细胞的作用来抑制排斥反应。
  • 批准号:
    05670509
  • 财政年份:
    1993
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
  • 批准号:
    MR/X008827/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients (Artemis)
加速虚拟双胞胎向脂肪肝患者个性化管理的转化(Artemis)
  • 批准号:
    10109933
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    EU-Funded
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
  • 批准号:
    10646759
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
脂肪肝疾病和血脂异常中的 NADH-ChREBP 轴
  • 批准号:
    10564369
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Development of Early Diagnostic Markers for Non-Alcoholic Fatty Liver Disease (NAFLD) and Investigation of Inflammatory Mechanisms of NAFLD
非酒精性脂肪性肝病(NAFLD)早期诊断标志物的开发及NAFLD炎症机制的研究
  • 批准号:
    23K07466
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tackling the fatty liver by targeting the gut
通过针对肠道来解决脂肪肝
  • 批准号:
    2869577
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship
Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease
非酒精性脂肪肝中基因组与重金属的相互作用
  • 批准号:
    10658148
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
AAV mediated gene knockdown of PIK3C2B as a therapeutic strategy for X-linked myotubular myopathy and fatty liver disease
AAV 介导的 PIK3C2B 基因敲低作为 X 连锁肌管肌病和脂肪肝的治疗策略
  • 批准号:
    10753786
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Bacteriotherapy to treat non-alcoholic fatty liver disease
细菌疗法治疗非酒精性脂肪肝
  • 批准号:
    2893992
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship
Investigating folliculin as a regulator of VLDL-TG secretion in non-alcoholic fatty liver disease and steatohepatitis
研究卵泡素作为非酒精性脂肪肝和脂肪性肝炎中 VLDL-TG 分​​泌的调节剂
  • 批准号:
    10679361
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了